Interleukin-2-induced hepatic injury involves temporal patterns of cell adhesion in the microcirculation

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 272, Issue 4 35-4, 1997, Pages

  Lentsch, Alex B ^a,b,c   Miller, Frederick N ^a,b   Edwards, Michael J ^a,b  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b University of Louisville School of Medicine   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

cytokines; hepatocellular injury; inflammation

Indexed keywords

RECOMBINANT INTERLEUKIN 2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; EDEMA; INFLAMMATION; INTRAPERITONEAL DRUG ADMINISTRATION; KIDNEY CARCINOMA; LEUKOCYTE ADHERENCE; LIVER INJURY; LIVER TOXICITY; MELANOMA; MICROCIRCULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; THROMBOSIS;

EID: 0030981235     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.1997.272.4.g727     Document Type: Article

References (22)

1. Anderson, J. A., A. B. Lentsch, D. J. Hadjiminas, F. N. Miller, A. W. Martin, K. Nakagawa, and M. J. Edwards. The role of cytokines, adhesion molecules, and chemokines in interleukin-2-induced lymphocytic infiltration in C57BL/6 mice. J. Clin. Invest. 97: 1952-1959, 1996.
2. Anderson, T. D., and T. J. Hayes. Toxicity of human recombinant interleukin-2 in rats. Pathologic changes are characterized by marked lymphocytic and eosinophilic proliferation and multi-system involvement. Lab. Invest. 60: 331-346, 1989.
3. Anderson, T. D., T. J. Hayes, M. K. Gately, J. M. Bontempo, L. L. Stern, and G. A. Truitt. Toxicity of human recombinant interleukin-2 in the mouse is mediated by interleukin-activated lymphocytes. Separation of efficacy and toxicity by selective lymphocyte subset depletion. Lab. Invest. 59: 598-612, 1988.
4. Bartlett, M. R., P. A. Underwood, and C. R. Parish. Comparative analysis of the ability of leucocytes, endothelial cells and platelets to degrade the subendothelial basement membrane: evidence for cytokine dependence and detection of a novel sulfatase. Immunol. Cell Biol. 73: 113-124, 1995.
5. Diacovo, T. G., K. D. Puri, R. A. Warnock, and T. A. Springer. Platelet-mediated lymphocyte delivery to high endothelial venules. Science 273: 252-255, 1996.
6. Edwards, M. J., B. T. Heniford, E. A. Klar, K. W. Doak, and F. N. Miller. Pentoxifylline inhibits interleukin-2-induced toxicity in C57BL/6 mice but preserves antitumor efficacy. J. Clin. Invest. 90: 637-641, 1992.
7. Edwards, M. J., F. N. Miller, D. E. Sims, D. L. Abney, D. A. Schuschke, and T. S. Corey. Interleukin 2 acutely induces platelet- and neutrophil-endothelial adherence and macromolecular leakage. Cancer Res. 52: 3425-3431, 1992.
8. Endo, Y., and M. Nakamura. Active translocation of platelets into sinusoidal and Disse spaces in the liver in response to lipopolysaccharides, interleukin-1 and tumor necrosis factor. Gen. Pharmacol. 24: 1039-1053, 1993.
9. Fujita, S., R. K. Puri, Z. X. Yu, W. D. Travis, and V. J. Ferrans. An ultrastructural study of in vivo interactions between lymphocytes and endothelial cells in the pathogenesis of the vascular leak syndrome induced by interleukin-2. Cancer 68: 2169-2174, 1991.
10. Fyfe, G., R. I. Fisher, S. A. Rosenberg, M. Sznol, D. R. Parkinson, and A. C. Louie. Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy. J. Clin. Oncol. 13: 688-696, 1995.
11. Gately, M. K., T. D. Anderson, and T. J. Hayes. Role of asialo-GM1-positive lymphoid cells in mediating the toxic effects of recombinant IL-2 in mice. J. Immunol. 141: 189-200, 1988.
12. House, S. D., and H. H. Lipowsky. Leukocyte-endothelium adhesion: microhemodynamics in mesentery of the cat. Microvasc. Res. 34: 363-379, 1987.
13. Lentsch, A. B., M. J. Edwards, and F. N. Miller. Interleukin-2 induces increased platelet-endothelium interactions: a potential mechanism of toxicity. J. Lab. Clin. Med. 128: 75-82, 1996.
14. Lindberg, R. A., D. W. Slaaf, A. B. Lentsch, and F. N. Miller. Involvement of nitric oxide and cyclooxygenase products in photoactivation-induced microvascular occlusion. Microvasc. Res. 47: 203-221, 1994.
15. McCuskey, R. S. Microscopic methods for studying the microvasculature of internal organs. In: Physical Techniques in Biology and Medicine Microvascular Technology, edited by C. H. Baker and W. F. Nastuk. New York: Academic, 1986, p. 247-264.
16. McCuskey, R. S., R. Urbaschek, P. A. McCuskey, and B. Urbaschek. Hepatic microvascular responses to tumor necrosis factor. In: Cells of the Hepatic Sinusoid, edited by E. Wisse, D. L. Knook, and K. Decker. Rijswijk, The Netherlands: Kupffer Cell Foundation, 1989, vol. 2, p. 272-276.
17. Miller, F. N., D. E. Sims, D. A. Schuschke, and D. L. Abney. Differentiation of light-dye effects in the microcirculation. Microvasc. Res. 44: 166-184, 1992.
18. Nakagawa, K., F. N. Miller, D. E. Sims, A. B. Lentsch, M. Miyazaki, and M. J. Edwards. Mechanisms of interleukin-2-induced hepatic toxicity. Cancer Res. 56: 507-510, 1996.
19. Oleksowicz, L., P. A. Paciucci, D. Zuckerman, A. Colorito, J. H. Rand, and J. F. Holland. Alterations of platelet function induced by interleukin-2. J. Immunother. 10: 363-370, 1991.
20. Oleksowicz, L., D. Zuckerman, Z. Mrowiec, E. Puszkin, and J. P. Dutcher. Effects of interleukin-2 administration on platelet function in cancer patients. Am. J. Hematol. 45: 224-231, 1994.
21. Welbourn, R., G. Goldman, L. Kobzik, I. Paterson, D. Shepro, and H. B. Hechtman. Interleukin-2 induces early multisystem organ edema mediated by neutrophils. Ann. Surg. 214: 181-186, 1991.
22. Welbourn, R., G. Goldman, L. Kobzik, C. R. Valeri, D. Shepro, and H. B. Hechtman. Involvement of thromboxane and neutrophils in multiple-system organ edema with interleukin-2. Ann. Surg. 212: 728-733, 1990.